Yahoo
NYSE - Nasdaq Real Time Price USD

Nuvation Bio Inc. (NUVB)

4.1600 -0.0300 (-0.72%)
At close: November 6 at 4:00:02 PM EST
4.1900 +0.0300 (+0.72%)
After hours: November 6 at 6:45:56 PM EST
Trade NUVB on Coinbase

News headlines

Updated 33m ago
Powered by Yahoo Scout

Nuvation Bio’s Q3 2026 results showed growing IBTROZI product revenue, strong cash resources, and continued development of safusidenib. The company also advanced its Phase 3 glioma program, while investors weigh persistent operating losses, market variability, and upcoming clinical data.

Mobilize your Website
View Site in Mobile | Classic
Share by: